This report presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales forecasts by country and market segment, including: – Hospitals – Commercial/Private Labs – Physician Offices – Public Health LabsIn addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of respiratory disease diagnostic products, by test and country. Also, the report: – Examines market applications of Molecular Diagnostics,Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; thirteen – Reviews features and operating characteristics of major analyzers usedfor respiratory disease testing; – Profiles key suppliers and potential market entrants developing innovativetechnologies and products; and – Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.MethodologyThe report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan. In addition to primary sources of information, a comprehensive review ofthe most recent technical and business publications, manufacturer productand financial literature, as well as Venture Planning Group’s proprietary data files was conducted.
Buy your copy of this report @ http://www.reportsnreports.com/reports/190563-future-horizons-in-the-global-respiratory-disease-market.html
Report Details:
Published: August 2012
No. of Pages: 366
Price:Single User License:US$9200 Corporate User License:US$19500
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. Adenovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
2. Influenza Viruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. Legionella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Mononucleosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Mycoplasma
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Pneumonia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
7. Respiratory Syncytial Virus (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Tuberculosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. France: Market Size, Growth and Major Suppliers’ Sales and Market Shares
IV. Germany: Market Size, Growth and Major Suppliers’ Sales and Market Shares
V. Italy: Market Size, Growth and Major Suppliers’ Sales and Market Shares
VI. Japan: Market Size, Growth and Major Suppliers’ Sales and Market Shares
VII. Spain: Market Size, Growth and Major Suppliers’ Sales and Market Shares
VIII. UK: Market Size, Growth and Major Suppliers’ Sales and Market Shares
IX. USA: Market Size, Growth and Major Suppliers’ Sales and Market Shares
Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Information Technology
D. Auxiliary Products
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges